Alpha phenyl-tert-butyl nitrone (PBN) protects syngeneic marrow transplant recipients from the lethal cytokine syndrome occurring after agonistic CD40 antibody administration

Blood

Volumn 105, Issue 1, 2005, Pages 428-431

  Gendelman, Maria ^b   Halligan, Nadine ^b   Komorowski, Richard ^b   Logan, Brent ^b   Murphy, William J ^b   Blazar, Bruce R ^b   Pritchard Jr , Kirkwood A ^b   Drobyski, William R ^a  

^a Bone Marrow Transplant Program   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD40 ANTIBODY; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; N TERT BUTYL ALPHA PHENYLNITRONE; NITRATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW TRANSPLANTATION; CYTOKINE SYNDROME; DRUG EFFECT; DRUG POTENTIATION; ENTEROPATHY; ISOGRAFT; LYMPHOMA; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPIN TRAPPING; SYNDROME; TUMOR IMMUNITY;

EID: 11144225851     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-01-0371     Document Type: Article

References (26)

1. Rosenberg SA, Lotze MT, Muul LM, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. New Engl J Med. 1985;313:1485-1492.
2. Lotze MT, Matory YL, Rayner AA, et al. Clinical effects and toxicity of interleukin-2 in patients with cancer. Cancer. 1986;58:2764-2772.
3. Wigginton JM, Komschlies KL, Back TC, Franco JL, Brunda MJ, Wiltrout RH. Administration of interleukin-12 with pulse interleukin-2 and the rapid and complete eradication of murine renal carcinoma. J Natl Cancer Inst. 1996;88:38-43.
4. Coughlin CM, Salhany KE, Wysocka M, et al. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest. 1998;101: 1441-1452.
5. French RR, Chan HTC, Tutt AL, Glennie MJ. CD40 antibody evokes a cytotoxic T cell response that eradicates lymphoma and bypasses T cell help. Nat Med. 1999;5:548-553.
6. Honeychurch J, Glennie MJ, Johnson PWM, Illidge TM. Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T cell dependent immunity to B cell lymphoma. Blood. 2003;102:1449-1457.
7. Bilber JL, Jabbour S, Parihar R, et al. Administration of two macrophage-derived interferon-gamma-inducing factors (IL-12 and IL-15) induces a lethal systemic inflammatory response in mice that is dependent on natural killer cells but does not require interferon gamma. Cell Immunol. 2002;216:31-42.
8. Okamoto M, Kato S, Oizumi K, et al. Interleukin 18 (IL-18) in synergy with IL-12 induces lethal lung injury in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia. Blood. 2002;99: 1289-1298.
9. Carson WE, Yu H, Dierksheide J, et al. A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol. 1999;162:4943-4951.
10. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft versus host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood. 1997;90:3204-3213.
11. Janzen EG, Haire DL. Two decades of spin trapping. In: Tanner DD, ed. Advances in Free Radical Chemistry. Greenwich, CT: JAI Press; 1990: 253-295.
12. Naito Y, Takagi T, Ishikawa T, et al. α-Phenyl-N-tert-butyl nitrone provides protection from dextran sulfate sodium-induced colitis in mice. Redox Signal. 2002;4:195-206.
13. Ho E, Chen G, Bray TM. Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkB activation offering protection against chemically induced diabetes. Free Rad Biol Med. 2000;28:604-614.
14. Kotake Y, Sang H, Wallis GL, Stewart CA. Phenyl N-tert-butyl nitrone provides protection from endotoxin shock through amplified production of the anti-inflammatory cytokine interleukin-10. Arch Biochem Biophys. 1999;371:129-131.
15. Hixon JA, Blazar BR, Anver MR, Wiltrout RH, Murphy WJ. Antibodies to CD40 induce a lethal cytokine cascade after syngeneic bone marrow transplantation. Biol Blood Marrow Transplant. 2001;7:136-143.
16. Hixon JA, Anver MR, Blazar BR, Panoskaltsis-Mortari A, Wiltrout RH, Murphy WJ. Administration of either anti-CD40 or interleukin-12 following lethal total body irradiation induces lethal toxicity affecting the gut. Biol Blood Marrow Transplant. 2002;8:316-325.
17. Tutt AL, O'Brien L, Hussain A, Crowther GR, French RR, Glennie MJ. T cell immunity to lymphoma following treatment with anti-CD40 monoclonal antibody. J Immunol. 2002;168:2720-2728.
18. Miyajima T, Kotake Y. Optimal time and dosage of phenyl N-tert-butyl nitrone (PBN) for the inhibition of nitric oxide synthase induction in mice. Free Rad Biol Med. 1997;22:463-470.
19. Sang H, Wallis GL, Stewart CA, Kotake Y. Expression of cytokines and activation of transcription factors in lipopolysaccharide-administered rats and their inhibition by phenyl N-tert-butylnitrone (PBN). Arch Biochem Biophysic. 1999;363: 341-348.
20. Tabatabaie T, Graham KL, Vasquez AM, Floyd RA, Kotake Y. Inhibition of the cytokine-mediated inducible nitric oxide synthase expression in rat insulinoma cells by phenyl N-tert-butyl nitrone. Nitric Oxide. 2000;4:157-167.
21. Kotake Y, Moore DR, Vasquez-Walden A, Tabatabaie T, Sang H. Antioxidant amplifies antibiotic protection in the cecal ligation and puncture model of microbial sepsis through interleukin-10 production. Shock. 2003;19:252-256.
22. Lee JH, Park J. Protective role of α-phenyl-N-t-butylnitrone against ionizing radiation in U937 cells and mice. Cancer Res. 2003;63:6885-6893.
23. Turner JG, Rakhmilevich AL, Burdelya L, et al. Anti-CD40 antibody induces antitumor and anti-metastatic effects: the role of NK cells. J Immunol. 2001;166:89-94.
24. Murphy WJ, Hixon J, Back T, et al. Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: coordination of dendritic and CDB cell responses. J Immunol. 2003;170:2727-2733.
25. Klausner JM, Paterson IS, Goldman G, et al. Interleukin-2-induced lung injury is mediated by oxygen free radicals. Surgery. 1991;109:169-175.
26. Samlowski WE, Petersen R, Cuzzocrea S, et al. A nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects. Nat Med. 2003;9:750-755.